AQP8 and glioma: Here, the sgRNA system was delivered via lentiviral vectors into glioma A172 and U251 cells that had been previously infected with the CRISPR/Cas9 lentiviral vector and selected by puromycin, which led to the knock-out of AQP8 in the two cell lines.